Back to Search
Start Over
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia.
- Source :
-
Leukemia [Leukemia] 2010 Apr; Vol. 24 (4), pp. 890-1. Date of Electronic Publication: 2010 Jan 21. - Publication Year :
- 2010
- Subjects :
- Aged
Alemtuzumab
Antibodies, Monoclonal pharmacology
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm pharmacology
Antineoplastic Agents pharmacology
Dose-Response Relationship, Drug
Female
Humans
Injections, Intravenous
Injections, Subcutaneous
Male
Middle Aged
Treatment Outcome
Antibodies, Monoclonal administration & dosage
Antibodies, Neoplasm administration & dosage
Antineoplastic Agents administration & dosage
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 24
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Editorial & Opinion
- Accession number :
- 20090782
- Full Text :
- https://doi.org/10.1038/leu.2009.297